Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 41 studies | 39% ± 16% | |
| connective tissue cell | 13 studies | 29% ± 9% | |
| endothelial cell of artery | 11 studies | 27% ± 13% | |
| myofibroblast cell | 6 studies | 29% ± 16% | |
| adventitial cell | 5 studies | 41% ± 17% | |
| smooth muscle cell | 4 studies | 28% ± 14% | |
| type I pneumocyte | 4 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 13561.31 | 458 / 459 | 94% | 38.37 | 1052 / 1118 |
| ovary | 98% | 11965.14 | 176 / 180 | 94% | 33.81 | 403 / 430 |
| thymus | 98% | 10075.04 | 642 / 653 | 89% | 22.76 | 540 / 605 |
| prostate | 89% | 6243.30 | 218 / 245 | 97% | 34.10 | 487 / 502 |
| lung | 100% | 19179.40 | 576 / 578 | 84% | 25.60 | 970 / 1155 |
| kidney | 92% | 11311.39 | 82 / 89 | 83% | 34.45 | 745 / 901 |
| uterus | 99% | 18747.99 | 169 / 170 | 70% | 24.41 | 321 / 459 |
| bladder | 100% | 13770.67 | 21 / 21 | 60% | 11.43 | 303 / 504 |
| adrenal gland | 87% | 7073.28 | 225 / 258 | 66% | 17.69 | 152 / 230 |
| esophagus | 77% | 5451.24 | 1107 / 1445 | 73% | 16.19 | 133 / 183 |
| skin | 90% | 14543.91 | 1624 / 1809 | 59% | 22.09 | 278 / 472 |
| intestine | 88% | 7398.22 | 847 / 966 | 60% | 13.36 | 315 / 527 |
| stomach | 72% | 6185.96 | 257 / 359 | 72% | 22.57 | 207 / 286 |
| pancreas | 45% | 1847.78 | 147 / 328 | 93% | 44.77 | 165 / 178 |
| adipose | 100% | 17152.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 42188.93 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 98% | 16116.59 | 235 / 241 | 0% | 0 | 0 / 0 |
| heart | 93% | 11532.43 | 804 / 861 | 0% | 0 | 0 / 0 |
| liver | 25% | 1086.01 | 56 / 226 | 57% | 13.47 | 230 / 406 |
| brain | 7% | 237.61 | 181 / 2642 | 65% | 19.38 | 461 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 10.23 | 30 / 45 |
| eye | 0% | 0 | 0 / 0 | 60% | 9.79 | 48 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 48% | 5.87 | 14 / 29 |
| muscle | 28% | 1106.27 | 221 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 3.80 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046903 | Biological process | secretion |
| GO_0048251 | Biological process | elastic fiber assembly |
| GO_2000121 | Biological process | regulation of removal of superoxide radicals |
| GO_0034394 | Biological process | protein localization to cell surface |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0071953 | Cellular component | elastic fiber |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0030023 | Molecular function | extracellular matrix constituent conferring elasticity |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005178 | Molecular function | integrin binding |
| Gene name | FBLN5 |
| Protein name | Fibulin 5 Fibulin-5 (FIBL-5) (Developmental arteries and neural crest EGF-like protein) (Dance) (Urine p50 protein) (UP50) Fibulin-5 |
| Synonyms | hCG_21251 DANCE UNQ184/PRO210 |
| Description | FUNCTION: Essential for elastic fiber formation, is involved in the assembly of continuous elastin (ELN) polymer and promotes the interaction of microfibrils and ELN . Stabilizes and organizes elastic fibers in the skin, lung and vasculature (By similarity). Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Vascular ligand for integrin receptors which may play a role in vascular development and remodeling . May act as an adapter that mediates the interaction between FBN1 and ELN . . |
| Accessions | ENST00000706676.1 A0A9L9PX66 A0A9L9PXD9 G3V3Y2 G3XA98 G3V4U0 ENST00000554468.5 Q9UBX5 ENST00000706677.1 ENST00000557088.6 ENST00000557570.2 ENST00000706680.1 ENST00000342058.9 G3V2P8 ENST00000267620.14 A0A9L9PY85 ENST00000706681.1 ENST00000706679.1 ENST00000556154.5 G3V329 |
